(Q41675711)

6 October 2017

title

Excess catecholamines and the metabolic syndrome: should central imidazoline receptors be a therapeutic target? (English)

1 reference

6 October 2017

Excess catecholamines and the metabolic syndrome: Should central imidazoline receptors be a therapeutic target? (English)

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

15 June 2024

0 references

1 reference

modelling biological systems

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7609678

15 June 2024

author name string

H. Rupp

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7609678

15 June 2024

R. Jacob

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7609678

15 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7609678

15 June 2024

publication date

1 March 1995

1 reference

full work available at URL

6 October 2017

https://api.elsevier.com/content/article/PII:0306987795901396?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

https://api.elsevier.com/content/article/PII:0306987795901396?httpAccept=text/plain

15 June 2024

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

15 June 2024

1 reference

6 October 2017

volume

44

1 reference

6 October 2017

issue

3

1 reference

6 October 2017

page(s)

217-225

1 reference

Reducing health care costs by reducing the need and demand for medical services. The Health Project Consortium

6 October 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Insulin resistance, hyperinsulinemia, and cardiovascular disease. The need for novel dietary prevention strategies

15 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Banting lecture 1988. Role of insulin resistance in human disease

15 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Epidemiologic and clinical aspects of insulin resistance and hyperinsulinemia

15 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp

15 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Insulin resistance is a characteristic feature of primary hypertension independent of obesity.

15 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Importance of obesity for the metabolic abnormalities associated with an abdominal fat distribution

15 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Influence of body fat distribution on free fatty acid metabolism in obesity

15 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Obesity, the sympathetic nervous system, and essential hypertension

15 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Insulin-mediated glucose metabolism in the relationship between dietary intake and sympathetic nervous system activity

15 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Autonomic nervous dysfunction in essential hypertension

15 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Insulin and blood pressure regulation

15 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Characteristics and mechanisms of tachyphylaxis of cardiac contractile response to insulin

15 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Sympathoadrenal activity in human obesity: heterogeneity of findings since 1980

15 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Islet function and stress hyperglycemia: plasma glucose and epinephrine interaction

15 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Galanin: a novel pancreatic neuropeptide

15 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Effect of catecholamines on glucose uptake and glycogenolysis in rat skeletal muscle

15 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

The interaction between the adenylate cyclase system and insulin-stimulated glucose transport. Evidence for the importance of both cyclic-AMP-dependent and -independent mechanisms

15 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Regional changes in adrenergic receptor status during hypocaloric intake do not predict changes in adipocyte size or body shape

15 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Hypertension and insulin resistance: role of sympathetic nervous system activity

15 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Decreased peripheral blood flow in the pathogenesis of the metabolic syndrome comprising hypertension, hyperlipidemia, and hyperinsulinemia

15 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Effect of positive inotropic agents on myosin isozyme population and mechanical activity of cultured rat heart myocytes

15 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

The hemodynamic link between insulin resistance and hypertension

15 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients

15 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Mechanisms involved in the regulation of the insulin secretory process

15 June 2024

39

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Effect of d- and dl-propranolol on glucose-stimulated insulin release

15 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension

15 June 2024

41

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

B cell adrenoceptors and sulphonylurea-induced insulin release in mouse islets

15 June 2024

42

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Discrimination between α2-adrenoceptors and [3H]idazoxan-labelled non-adrenergic sites in rabbit white fat cells

15 June 2024

46

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Non-adrenergic binding sites for the “α2-antagonist” [3h]idazoxan in the rabbit urethral smooth muscle pharmacological and biochemical characterization

15 June 2024

47

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Keeping an eye on the I site: imidazoline-preferring receptors

15 June 2024

49

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

An endogenous substance with clonidine-like properties: selective binding to imidazole sites in the ventrolateral medulla

15 June 2024

50

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Clonidine-displacing substance (CDS) and its putative imidazoline receptor. New leads for further divergence of alpha 2-adrenergic receptor activity

15 June 2024

51

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Agmatine: an endogenous clonidine-displacing substance in the brain

15 June 2024

52

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Monosynaptic connection from caudal to rostral ventrolateral medulla in the baroreceptor reflex pathway

15 June 2024

53

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Ventral medullary relay neurones in the pathway from the defence areas of the cat and their effect on blood pressure.

15 June 2024

54

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Imidazoline receptors. A new concept in central regulation of the arterial blood pressure

15 June 2024

56

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Vasopressor and depressor areas in the rat medulla. Identification by microinjection of L-glutamate.

15 June 2024

59

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Some properties of the sympathoinhibition from the caudal ventrolateral medulla oblongata in the cat

15 June 2024

61

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Differential control of sympathetic fibres supplying hindlimb skin and muscle by subretrofacial neurones in the cat.

15 June 2024

63

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Crossover comparison of moxonidine and clonidine in mild to moderate hypertension

15 June 2024

66

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Pharmacodynamic action and pharmacokinetics of moxonidine after single oral administration in hypertension patients

15 June 2024

67

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Evidence that locus coeruleus is the site where clonidine and drugs acting at alpha 1- and alpha 2-adrenoceptors affect sleep and arousal mechanisms

15 June 2024

71

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

The haemodynamic and hormonal responses after clonidine occur independently of sedation in essential hypertension

15 June 2024

72

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

The effect of clonidine on centrally and peripherally evoked submaxillary salivation

15 June 2024

73

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Distinctive features of rilmenidine possibly related to its selectivity for imidazoline receptors

15 June 2024

74

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Binding of [3H]clonidine to I1-imidazoline sites in bovine adrenal medullary membranes

15 June 2024

75

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Psychosocial and biobehavioral characteristics of hypertensive men with elevated atherogenic lipids

15 June 2024

79

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

The role of hypertension, left ventricular hypertrophy and psychosocial risks in cardiovascular disease: prospective evidence from blue-collar men

15 June 2024

80

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Visceral fat accumulation: the missing link between psychosocial factors and cardiovascular disease?

15 June 2024

82

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Differential effect of physical exercise routines on ventricular myosin and peripheral catecholamine stores in normotensive and spontaneously hypertensive rats

15 June 2024

83

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Mortality from circulatory diseases in Norway 1940-1945

15 June 2024

84

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

Stress response pattern in obesity and systemic hypertension.

15 June 2024

85

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90139-6

15 June 2024

Identifiers

1 reference

6 October 2017

1 reference